Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7326
PUT
United States Lime & Minerals
USLM
$3.38B
| $863K | ﹤0.01% |
+6,500
| New | +$824K |
|
7327
iShares Europe ETF
IEV
$1.68B
| $863K | ﹤0.01% |
16,569
+7,793
| +89% | +$426K |
|
7328
PUT
Corvus Pharmaceuticals
CRVS
$1.25B
| $862K | ﹤0.01% |
161,200
+135,400
| +525% | +$1.01M |
|
7329
Fidelity MSCI Health Care Index ETF
FHLC
$3.44B
| $862K | ﹤0.01% |
+13,186
| New | +$916K |
|
|
SMST
7330
CALL
Defiance Daily Target 2x Short MSTR ETF
SMST
$29.9M
| $862K | ﹤0.01% |
+5,165
| New | +$2.27M |
|
7331
CALL
ChargePoint
CHPT
$144M
| $861K | ﹤0.01% |
40,250
+2,595
| +7% | +$64.2K |
|
7332
Planet Labs
PL
$8.33B
| $860K | ﹤0.01% |
212,878
+178,097
| +512% | +$553K |
|
7333
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.42B
| $860K | ﹤0.01% |
9,051
-13,011
| -59% | -$1.24M |
|
7334
CALL
Select Water Solutions
WTTR
$2.72B
| $859K | ﹤0.01% |
64,900
-13,900
| -18% | -$177K |
|
7335
PUT
Rocket Pharmaceuticals
RCKT
$367M
| $859K | ﹤0.01% |
68,300
+49,700
| +267% | +$748K |
|
7336
Caledonia Mining Corp
CMCL
$446M
| $858K | ﹤0.01% |
91,185
+42,868
| +89% | +$548K |
|
7337
CALL
Krispy Kreme
DNUT
$562M
| $858K | ﹤0.01% |
86,400
-56,100
| -39% | -$607K |
|
7338
CALL
Itron
ITRI
$4.21B
| $858K | ﹤0.01% |
7,900
-19,500
| -71% | -$2.18M |
|
7339
Gold Royalty Corp
GROY
$725M
| $857K | ﹤0.01% |
708,444
-425,726
| -38% | -$568K |
|
|
CTLP
7340
DELISTED
Cantaloupe
CTLP
| $857K | ﹤0.01% |
90,085
+65,185
| +262% | +$593K |
|
7341
CALL
TD Synnex
SNX
$20.8B
| $856K | ﹤0.01% |
7,300
-4,900
| -40% | -$587K |
|
7342
CALL
Wave Life Sciences
WVE
$1.04B
| $856K | ﹤0.01% |
69,200
+58,800
| +565% | +$785K |
|
7343
Sierra Bancorp
BSRR
$527M
| $855K | ﹤0.01% |
29,579
+21,849
| +283% | +$654K |
|
7344
Franklin FTSE Taiwan ETF
FLTW
$3.43B
| $855K | ﹤0.01% |
18,075
+9,116
| +102% | +$444K |
|
|
RVNC
7345
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
| $855K | ﹤0.01% |
281,200
+209,100
| +290% | +$911K |
|
7346
CALL
Artivion
AORT
$1.41B
| $855K | ﹤0.01% |
29,900
+9,400
| +46% | +$261K |
|
7347
National Bank Holdings
NBHC
$1.91B
| $855K | ﹤0.01% |
+19,848
| New | +$899K |
|
7348
Zymeworks
ZYME
$1.85B
| $854K | ﹤0.01% |
58,358
+37,550
| +180% | +$525K |
|
7349
First Trust Intermediate Government Opportunities ETF
MGOV
$100M
| $853K | ﹤0.01% |
+43,020
| New | +$869K |
|
7350
CALL
Kymera Therapeutics
KYMR
$10.1B
| $853K | ﹤0.01% |
21,200
-3,400
| -14% | -$154K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.